A COVID Story That Refuses to End Quietly: Miranda Devine Revisits the Record
Miranda Devine's article revisits the U.S. COVID-19 vaccine rollout, highlighting discrepancies between early public health messaging and later-emerging data, particularly regarding vaccine effectiveness and transparency. It points to internal FDA and CDC communications, including concerns raised by Dr. Ana Szarfman, who was reportedly silenced while analyzing vaccine safety data. The piece underscores ongoing debates over federal mandates, data sharing, and public trust in health institutions during the pandemic.
Opening excerpt (first ~120 words) tap to expand
A COVID Story That Refuses to End Quietly: Miranda Devine Revisits the Record David Manney | 10:48 PM on April 30, 2026 AP Photo/J. Scott Applewhite The COVID chapter never closed the way many expected; it didn't end with a clean summary or a shared understanding of what worked and what didn't. It ended with questions pushed aside and timelines that never fully lined up. Advertisement googletag.cmd.push(function () { googletag.display("div-gpt-300x250_3"); //googletag.pubads().refresh([gptAdSlot["div-gpt-300x250_3"]]) }); Now those questions keep coming back.The New York Post's Miranda Devine laid out a case that revisits the vaccine rollout, the messaging that followed, and the consequences that came with both.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at PJ Media.
Discussion
0 commentsMore from PJ Media
